Victory Pharma
Leveraging science-based heritage to develop and commercialize pharmaceutical products to treat unmet medical needs in the areas of infectious diseases and pain.
HQ location
Florham Park, United States
Website
Launch date
Employees
Market cap
$16.6b
Enterprise value
$11.8b
Share price
JPY2570.00 4507.T
Recent deals
Notable known LPs
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
* | $118m | Acquisition | |
$7.6m | Grant | ||
| Total Funding | $7.6m | ||
| JPY | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | (11 %) | 13 % | 27 % | 2 % | 1 % | 13 % | 10 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 53 % | 43 % | 57 % | 51 % | 53 % | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 38 % | 34 % | 43 % | 37 % | 39 % | - | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 18 % | 22 % | 24 % | 24 % | 25 % | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
